home / stock / bhc / bhc news

BHC News and Press, Bausch Health Companies Inc. From 01/18/24

Stock Information
Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC
Market: NYSE
Website: bauschhealth.com
Menu
BHC BHC Quote BHC Short BHC News BHC Articles BHC Message Board
Get BHC Alerts

News, Short Squeeze, Breakout and More Instantly...
BHC - Bausch gets Chinese approval for Thermage FLX and TR-4 return pad

2024-01-18 13:26:46 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
BHC - Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics market, today announced the approval of The...

BHC - (BHC) On The My Stocks Page

2024-01-17 03:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BHC - Bausch Health gains after an appeals hearing in Norwich case over generic Xifaxan

2024-01-08 13:53:28 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...
BHC - Bausch + Lomb wins FDA nod for eye surgery product

2024-01-08 08:31:17 ET More on Bausch Health, Bausch + Lomb, etc. Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch re...

BHC - Bausch reports positive Phase 2 data for ulcerative colitis drug

2023-12-21 12:59:06 ET More on Bausch Health Companies Bausch Health: $20bn Debt Is A Mighty Elephant In The Room Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation B...

BHC - Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis

Trial Meets Both Primary and Key Secondary Endpoints LAVAL, QC / ACCESSWIRE / December 21, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive topline results from the Company's Phase 2 study evaluating Amiselimod, an investigat...
BHC - Tracking John Paulson's Paulson & Company Portfolio - Q3 2023 Update

2023-12-19 22:37:01 ET Summary John Paulson's 13F portfolio value increased by 9% to $1.12 billion this quarter. The top five positions in the portfolio were Horizon Therapeutics, Bausch Health, Brightsphere Investment Group, NovaGold, and Perpetua Resources. Paulson's stake i...

BHC - DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec's Public Drug Plan

LAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045% w/w tazarotene), the company's novel topical prescrip...

BHC - Tracking Carl Icahn's 13F Report - Q3 2023 Update

2023-12-10 22:56:31 ET Summary Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. The top five holdings in the filing are Icahn Enterprises, CVR Energy, Occidental Petroleum warrants, Southwest Gas Holdings, and FirstEnergy. Icahn disposed of his stake in X...
Previous 10 Next 10